| |
| |
|
| Insider
Information: |
Lichtinger Pedro |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
833,366 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$637,741 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
833,366 |
|
|
| Total
Value |
$637,741 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Optimer Pharmaceuticals Inc |
OPTR |
Former CEO |
2013-04-08 |
104,078 |
2010-11-15 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2013-06-04 |
126,250 |
2012-04-11 |
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
Chief Executive Office... |
2015-02-09 |
528,205 |
2014-06-09 |
0 |
Premium* |
|
|
NeuroBo Pharmaceuticals Inc |
NRBO |
Director |
2019-07-24 |
74,833 |
2016-08-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NRBO |
NeuroBo Pharmaceuticals I... |
Director |
– • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
74,833 |
0 |
- |
|
| NRBO |
NeuroBo Pharmaceuticals I... |
Director |
– • – |
2017-03-10 |
4 |
B |
$9.47 |
$99,994 |
D/D |
10,559 |
59,833 |
2.39 |
- |
|
| NRBO |
NeuroBo Pharmaceuticals I... |
Director |
– • – |
2016-08-10 |
4 |
B |
$10.00 |
$100,000 |
D/D |
10,000 |
49,274 |
2.39 |
- |
|
| NRBO |
NeuroBo Pharmaceuticals I... |
Director |
– • – |
2016-08-10 |
4 |
OE |
$6.71 |
$263,368 |
D/D |
39,274 |
39,274 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
Chief Executive Officer |
• • – |
2015-02-09 |
4 |
B |
$3.90 |
$500,000 |
D/D |
128,205 |
528,205 |
2.81 |
- |
|
| AST |
Asterias Biotherapeutics ... |
Chief Executive Officer |
• – – |
2014-06-12 |
4 |
A |
$2.34 |
$468,000 |
D/D |
200,000 |
400,000 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
Chief Executive Officer |
• – – |
2014-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
200,000 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2013-06-04 |
4 |
B |
$0.00 |
$0 |
D/D |
120,000 |
126,250 |
2.31 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Former CEO |
– – – |
2013-04-08 |
4 |
S |
$14.63 |
$2,173,991 |
D/D |
(148,000) |
104,078 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Former CEO |
– – – |
2013-04-08 |
4 |
S |
$14.63 |
$2,173,991 |
D/D |
(148,000) |
104,078 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Former CEO |
– – – |
2013-04-08 |
4 |
OE |
$11.41 |
$1,877,680 |
D/D |
148,000 |
252,078 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and President |
• – – |
2012-11-08 |
4 |
B |
$9.08 |
$99,847 |
D/D |
11,000 |
104,078 |
2.74 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and President |
• • – |
2012-05-15 |
4 |
A |
$9.72 |
$21,247 |
D/D |
2,185 |
93,078 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2012-04-11 |
4 |
B |
$3.98 |
$24,850 |
D/D |
6,250 |
6,250 |
2.39 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and President |
• – – |
2011-11-15 |
4 |
A |
$9.72 |
$1,682 |
D/D |
173 |
90,893 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and President |
• • – |
2011-08-04 |
4 |
B |
$8.98 |
$224,450 |
D/D |
25,000 |
90,720 |
2.81 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and President |
• • – |
2011-06-30 |
4 |
A |
$11.89 |
$249,690 |
D/D |
21,000 |
65,720 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and President |
• • – |
2011-05-27 |
4 |
A |
$12.34 |
$246,800 |
D/D |
20,000 |
44,720 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and President |
• – – |
2011-05-16 |
4 |
A |
$7.71 |
$19,274 |
D/D |
2,500 |
24,720 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
President and CEO |
• • – |
2011-02-02 |
4 |
A |
$12.34 |
$246,800 |
D/D |
20,000 |
22,200 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
CEO and President |
• – – |
2010-11-15 |
4 |
A |
$7.71 |
$17,115 |
D/D |
2,220 |
2,220 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
